| __timestamp | Grifols, S.A. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 100244000 |
| Thursday, January 1, 2015 | 224193000 | 29674000 |
| Friday, January 1, 2016 | 197617000 | 14917000 |
| Sunday, January 1, 2017 | 288320000 | 14118000 |
| Monday, January 1, 2018 | 240661000 | 8737000 |
| Tuesday, January 1, 2019 | 276018000 | 6900000 |
| Wednesday, January 1, 2020 | 294216000 | 6248000 |
| Friday, January 1, 2021 | 354881000 | 12312000 |
| Saturday, January 1, 2022 | 361140000 | 19721000 |
| Sunday, January 1, 2023 | 330551000 | 31283000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Grifols, S.A. has consistently outpaced MannKind Corporation in R&D investment. From 2014 to 2023, Grifols increased its R&D spending by approximately 83%, peaking in 2022. In contrast, MannKind's R&D expenses fluctuated, with a notable decline of around 69% from 2014 to 2019, before a modest recovery in recent years.
This strategic focus on R&D by Grifols underscores its dedication to advancing medical solutions, while MannKind's variable investment reflects a more cautious approach. As the industry evolves, these spending patterns may influence each company's ability to innovate and capture market share. Understanding these trends provides valuable insights into the strategic priorities of these pharmaceutical giants.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
Research and Development Expenses Breakdown: Grifols, S.A. vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation
Research and Development Expenses Breakdown: Opthea Limited vs MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Amneal Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and MannKind Corporation
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.